Janus Henderson Group PLC Raises Holdings in CVS Health Co. (NYSE:CVS)

Janus Henderson Group PLC lifted its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 0.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 765,186 shares of the pharmacy operator's stock after acquiring an additional 4,283 shares during the period. Janus Henderson Group PLC owned approximately 0.06% of CVS Health worth $34,352,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Whitebox Advisors LLC purchased a new stake in CVS Health in the fourth quarter valued at approximately $249,000. Hall Laurie J Trustee boosted its position in CVS Health by 25,484.4% in the fourth quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator's stock valued at $517,000 after buying an additional 11,468 shares during the last quarter. B&D White Capital Company LLC purchased a new stake in CVS Health in the fourth quarter valued at approximately $417,000. Fairfax Financial Holdings Ltd. Can purchased a new stake in CVS Health in the fourth quarter valued at approximately $121,742,000. Finally, Seizert Capital Partners LLC boosted its position in CVS Health by 22.8% in the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after buying an additional 105,708 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Trading Down 0.8%

Shares of CVS stock opened at $60.03 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company has a market cap of $75.94 billion, a price-to-earnings ratio of 16.40, a PEG ratio of 0.98 and a beta of 0.60. The stock has a 50 day simple moving average of $66.71 and a 200-day simple moving average of $59.15. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period in the prior year, the company posted $1.31 EPS. The business's quarterly revenue was up 7.0% on a year-over-year basis. On average, equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.43%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 63.48%.

Analysts Set New Price Targets

A number of brokerages recently commented on CVS. Argus set a $77.00 target price on CVS Health in a research report on Tuesday, February 18th. Evercore ISI upped their target price on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. Royal Bank of Canada raised their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Truist Financial raised their price target on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Monday. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $74.94.

Insider Activity at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This represents a 47.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael F. Mahoney bought 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the acquisition, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.